Twitxy Saved

Ian C. Bostock MD, MS

@IanCBostock1

Thoracic Surgeon @MiamiCancerInst | Health Services Researcher | 🫁 πŸ¦€ πŸ‘¨πŸ»β€βš•οΈπŸ‡²πŸ‡½ @BrighamSurgery @DartSurgery @MDAndersonNews @LatinoSurgery #endcancer
Miami, FL Joined January 2020
322 Following 739 Followers 530 Posts

Latest posts 5

Ian C. Bostock MD, MS @IanCBostock1
Totally agree! We have to be more proactive! πŸ₯Š
Elliot Servais, MD, FACS Verified account @ElliotServaisMD Jun 4, 2025
RiskReveal was presented at ASCO. Gene analysis of resected stage 1 tumors predicted those that benefit from adjuvant.

To me, these are tumors with occult micrometastatic disease. We should move these types of assays into the preoperative setting to select for early stage patients who could benefit from induction chemo-ICI
View quoted post on X